A change in paradigm is needed in the prevention of toxic effects on the nervous system, moving from its the present reliance solely on data from animal testing to a prediction model mostly based on in vitro toxicity testing and in silico modelling.
Introduction.
The founder of modern toxicology, Mateu Orfila (1787 Orfila ( -1853 , recognized that toxic effects on the nervous system include extreme diversities of both causes and outcomes (Orfila, 1826) . The extreme diversity of cell types and cell interactions included in the nervous system, and the associated selectivity that most toxic actions show for a single or a limited number of these kinds of cells (Spencer, 2000) make predicting toxicity in this system a challenging task within the view proposed by the report "Toxicity testing in the 21 st century: A vision and a strategy" (NRC, 2007) . This report advocates for a toxicity testing strategy that relies on high throughput in vitro tests sensitive to key effects on "toxicity pathways". In the era of molecular cell biology, robotics and informatics, this proposal seems a good one, but whether or not it will really answer the needs is an open question. Many meetings and symposia have focused on the results obtained in the development of methods for high throughput testing. However, there is also a need for debating the overall strategy, and for evaluating fundamental aspects of neurotoxicity studies that are relevant to the value of the testing schemas.
This article summarizes a symposium entitled Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it that was presented at the
Xi'an International Neurotoxicology Conference, Neurotoxicity and Neurodegeneration:
Local Effect and Global Impact held on June 5-10, in Xi'an, China. The first speaker in this symposium, Dr. Abby Li, reviewed the current test guidelines for adult and developmental neurotoxicity testing, and extended on the needs and challenges involved in the transition from the present scenario to the one envisaged by the NRC 21 st century vision report. The second speaker, Dr. Jordi Llorens, defended the hypothesis that we may go beyond the NRC 21 st century proposal and also start preparing for a long term goal of a complete in silico neurotoxicity prediction. He reviewed the role of the taste and olfactory systems in toxic avoidance by living mammals to conclude that a great effort in in vivo toxicity studies is also necessary to collect a database of toxic effects related to chemical epitopes, on which the in silico modeling can be based. The two remaining talks reviewed the results from the author's own laboratories that are of highly relevance for future developments of in vitro testing strategies. One major challenge to these strategies is the need to evaluate the potential of chemicals for chronic neurotoxicity and neurodevelopmental toxicity. Dr. Sandra
Ceccatelli reported on her studies using neuronal stem cells for in vitro neurotoxicity evaluation, as chemicals with preferential activity against these cells are likely to be neurodevelopmental toxicants. She showed how the phenomena of cell proliferation, differentiation and migration can be studied in these cells, and the impact of neurotoxic exposure on these parameters that are well recognized as critical points in neurodevelopment. The fourth speaker, Dr. Cristina Suñol, reviewed her results using neuronal cell cultures exposed to environmental pollutants for several days. Her results indicate that neuronal in vitro systems can be used not only to evaluate cytotoxic effects, but also to assess more subtle effects such as the establishment of persistent changes in synaptic transmission, more likely to be relevant for chronic neurotoxicity and neurodevelopmental toxicity. Together, the symposium contributed to the debate about how we will predict neurotoxicity and neurodevelopmental toxicity in the future.
Regulatory Neurotoxicity Testing for Risk Assessment Purposes: Current and
Future Approaches.
Abby A. Li, Ph.D. Exponent Health Sciences, San Francisco, USA Current test guidelines for standard toxicity testing, acute and subchronic neurotoxicity testing, and developmental neurotoxicity (DNT) testing rely primarily on behavioral and histopathology evaluations of the nervous system (Tables 1 and 2 ). For example, the DNT test requires an evaluation of different types of behavioral measures including gross neurologic and behavioral abnormalities, motor activity, startle habituation and neuropathologic evaluations including morphometric measures (Table   2 ). This test is designed to assess different types of behavioral functions and evaluate histopathology sections throughout the central and peripheral nervous system. The study designs require three treatment groups and one control group with the highest dose level inducing systemic toxicity, but not death or severe suffering of the animals.
EPA's Neurotoxicity Risk Assessment Guidelines (USEPA, 1998) and OECD's guidance document on neurotoxicity testing (OECD, 2004) provide guidance on interpreting functional and morphologic changes. Specifically, changes in behavior may be adverse but are not necessarily the result of a direct effect on the nervous system, especially when testing chemicals near the maximum tolerated dose (USEPA, 1998) . In addition, evaluation of whether behavioral changes are adverse should take into consideration the consistency of the pattern of effects. For example, in evaluating results from the functional observational battery (FOB), which can include more than 30 different measures of normal and/or abnormal behaviors, "the risk assessor should be aware of the potential for a number of false positive statistical findings in these studies because of the large number of endpoints customarily included in the FOB" (USEPA, 1998) . OECD (2004) and USEPA (1998) recommend that the assessment of neurotoxicity should incorporate a level of concern based on the type, severity, number, and either full or partial reversibility of the effect(s). A pattern or cluster of related effects generally causes a higher level of concern than individual or unrelated effects. However, the observation of some specific endpoints, even those of limited duration in time (e.g., body tremors, convulsions) may be sufficiently important depending on dose level and relative sensitivity compared to other toxicity endpoints (OECD, 2004 Century (NRC, 2007, p.28) , which concluded that the intensity and depth of testing should focus resources on the evaluation of the more sensitive adverse effects of exposures of greatest concern rather than on full characterization of all adverse effects irrespective of relevance for risk-assessment and risk-management needs. It also stated that testing strategies need to balance the depth and breadth of testing with animal welfare concerns and expenditure of money and time on testing and regulatory review. This tiered testing approach depends on a first tier of testing that adequately and rapidly screens for a large number of chemicals for all endpoints of importance including neurotoxicity in adult and developing animals.
Current test methods for neurotoxicity testing, especially DNT, are resource intensive and use a large numbers of animals (at least 900 animals for DNT studies).
Draft OECD guidelines for an extended 1-generation study include DNT endpoints as a means of combining elements of DNT testing with a reproduction study (OECD, 2010, Table 2 ). In addition, some of the behavioral endpoints may have high inherent or experimental variability (Raffaele et al., 2008) . This variability is a result, in part, to the fact that 20-40 pups/litter/dose level must be tested at specific ages over a span of 4-5 days depending on when the pups from all litters are born. These studies could be conducted using staggered start dates for different replicates, but extending testing across weeks or months can contribute further to variability of the data. Thus, approaches that might improve screening of potential neurotoxicants could aid in prioritizing chemicals for further neurotoxicity testing.
The new NRC 21 st century vision emphasizes the use of high-throughput assays, computational tools, and scientific advances in understanding perturbations of cellular-response networks-complex interaction of genes, proteins, and small molecules-that lead to adverse health effects (Judson et al., 2010; Martin et al., 2011; NRC, 2007) . Other approaches include the use of a battery of medium-throughput in vitro cell culture assays to model key events of brain development such as proliferation, differentiation, migration, neurite growth, synaptogenesis, myelination, and apoptosis.
Additionally, alternative nonmammalian species (e.g., zebrafish, C. elegans) can be used to screen for chemical effects on an intact rapidly developing nervous system (Coecke et al., 2007; Lein et al., 2005 Lein et al., , 2007 MacPhail et al., 2009; Radio and Mundy, 2008; Ton et al. 2006 ).
There are significant challenges in realizing this vision for toxicity testing. (Crofton et al., 2011) . In addition, specific criteria based on these general principles outlined by Crofton et al. (2011) should be inclusion criteria for any exploratory data-mining computational efforts. At present, it is premature to make any conclusions about which battery of in vitro methods, if any, will improve developmental neurotoxicity testing.
An integral part of the NRC 21 st century vision that has not been given sufficient attention is the use of targeted testing to complement toxicity pathway tests and to support toxicity evaluation for risk assessment purposes. Targeted properly validated, these approaches will improve screening of chemicals for potential neurotoxicity and focus additional testing resources towards those chemicals of greatest concern. directions. This part of the symposium discussed the strategy used by mammals for toxicity avoidance, with the purpose of learning about a quite successful strategy from which some useful ideas may emerge. No long ago, we prevented toxicity as wild mammals using our sensory systems to avoid ingestion of toxic foods. Many factors now make this biological system for (neuro)toxicity prevention an insufficient one.
These include 1) dermal and inhalation routes of exposure are increasingly significant in contrast to the oral route that likely predominated toxic exposure during evolution; 2) high concentrations of lipophilic compounds are likely more abundant in our present environment than in common foods of the pre-Neolithic times; 3) toxic molecules may belong to new classes of compounds, differing from anything we have encountered previously during evolution; 4) increased life expectancy makes the long term, delayed or cumulative effects much more important. This is an aspect in which the nervous system emerges as the main one of concern because of its limited capacity for regeneration. These factors make it important that toxicological sciences help us to prevent toxic damage, but they do not invalidate the logic behind the biological strategy, which has been quite successful. Modern biological sciences provide an overall understanding of some major features of sensory physiology, and we can hypothesize how they act in toxicity prevention and perhaps learn some useful lessons.
Chemical components included in food are analyzed by two major sensory systems, the taste system in the oral cavity and the olfactory system by the retronasal route. In the taste system, each taste cell selectively responds to one of a few basic taste modalities (for a review, see Chandrashekar et al., 2006) , five of which are currently recognized: salty, sour, bitter, sweet and umami. Some other basic tastes may exist, as one for lipids, but the list is quite short in any case. The bitter taste is the one that specializes in detecting toxic compounds to be avoided, although extremely salty and sour tastes also generate avoidance responses. Bitter compounds are those that bind to bitter taste receptors, a family of around thirty G-protein coupled receptors known as T2Rs (for taste-2 receptors) (Adler et al., 2000) . All of these bitter receptors are expressed in the same taste cells, which act as broadly tuned bitter sensors that are wired to mediate behavioral aversion and differ from the ones mediating the other taste modalities (Mueller et al, 2005) . This organization has some important implications.
First, there is one single bitter perception, we can discriminate among different concentrations of bitter compounds, but we cannot distinguish among different classes of bitter compounds. Second, our ability to detect toxic compounds by their taste depends on genetic information encoded in the bitter receptors. Third, the bitter receptors are likely adjusted to bind compounds with a relevant toxic role during our evolutionary history. Fourth, the small number of existing T2Rs, 25 in humans, implies that, even if broadly tuned, only a few hundred bitter compounds are probably detectable. Thus, the bitter taste system seems adapted to provide a fast warning signal for bulk content of toxins in food, but with no discrimination ability (Yarmolinsky et al., 2009 ).
In contrast to the few modalities existing for taste perception, there are no basic modalities for olfactory perception. There are hundreds of different olfactory receptors (339 in humans, 913 in mice) and each of them is expressed in a specific population of olfactory neurons that will respond to chemicals binding to this particular receptor (Buck and Axel, 1991; Uchida et al., 2000; reviewed by DeMaria and Ngai, 2010) . Each olfactory receptor (and therefore each class of olfactory neuron) is activated by compounds with certain molecular features (e.g., aldehydes), but is also broadly tuned for other characteristics (e.g. carbon chain length). The receptor does not recognize the entire molecule, but a part of it, a "chemical epitope", and will be activated by different molecules that have this epitope in common. Overall, the olfactory system uses several hundreds of receptors for chemical recognition to respond to an endless list of molecules, each encoded as a particular combination of chemical epitopes; it is a system for detailed chemical analysis with a very high capacity for discrimination. This capacity for discrimination can be used for toxic avoidance following rules that are learned. It is well known that mammals develop robust avoidance responses to flavors once paired with sickness (Garcia et al., 1955) . Current knowledge on the physiology of the taste and smell systems indicates that the olfactory system must be the main one involved in the chemical recognition necessary for this response.
The mammalian system for avoiding toxicity is thus based in two complementary strategies. First, the taste system is used to avoid ingestion of toxic doses of potentially harmful compounds as genetically encoded in the bitter receptors.
Second, foods and drinks accepted by the taste system are submitted to a detailed chemical analysis and refused in the future if signals of disease (pain, nausea, dizziness) follow the previous ingestions.
The proposed strategy for toxicity testing based on high throughput in vitro tests sensitive to key effects on toxicity pathways will, if successful, provide a system that will share many features with the taste system. Test validation will take place of evolutionary selection, and the process will likely provide a limited number of test systems for high throughput toxicity testing, as we have a limited number of bitter taste receptors for quick rejection of toxic compounds. These systems will have limitations imposed by the currently available knowledge in the same way that bitter receptors likely recognize only toxic compounds that we have encountered in significant amounts during evolution. So we will need a second system that, like the avoidance learning system based on olfactory information, is open to learning about new toxic effects caused by new compounds that have passed the first screen. The advantage now is that any new knowledge will persist and not disappear, in the way that flavor aversions are lost when the subject dies.
Our system open to learning will necessarily cover some gaps in the biological system, including associations for chronic and delayed toxicity, but other parts can be mimicked. In particular, the "chemical epitope" approach of describing the chemical world used by the olfactory system is likely to be useful in terms of toxicity prediction, and is likely to be particularly well suited for in silico modeling. Because a few hundreds of olfactory receptors exist, perhaps a similar or a few times greater number of epitope descriptor models (from 300 to 3,000 in total) could be enough (that is, any chemical potentially interacting with our organism could be satisfactorily described as a Besides chemical description, the system will need toxicity data for pairing chemical epitopes with the toxicity outcomes. In my opinion, because they include the largest possible variety of initial targets and integrate all the necessary parameters involved in toxicity outcome, in vivo studies, using multiple species and paradigms, are likely to be the most efficient way to generate the needed knowledge, whatever the toxicity pathways linking the initial targets to the final toxic effect. Although we know about the many kinetic and dynamic variables involved in any toxic effect, it is compelling to recognize that the natural avoidance system simply pairs olfactory chemical analysis with a few apical indices of illness. Also, the nervous system may include many unique toxicity pathways, but its singularity for toxicity more likely relies on the diversity of initial targets it contains.
The above information leads me to express two proposals. The first major proposal is that in addition to developing tests for high throughput toxicity testing we need to make a huge effort of data collection, including much in vivo data, to approach the dreamed end goal of in silico toxicity prediction. In vivo testing represents the evaluation of an unbeatable diversity of potential targets that we need to take into account in our efforts to toxicity prediction. It is obvious that we cannot test all chemicals in live mammals, but there is a lot that we need to learn from in vivo models, including mammalian species. A relevant effort generating useful data is that of the pharmaceutical industry in both pre-clinical tests and clinical trials; how we get to use this information is a relevant question. Although pharmaceuticals are intentionally designed to minimize their toxicity and are thus a biased sample of the chemical universe, the discovery of unexpected toxic effects associated with new chemical epitopes may provide useful cues for subsequent in silico toxicity prediction.
Importantly, if toxic effects are found at the clinical trial level, after extensive pre-clinical testing, this indicates human-specific effects.
A second proposal is that we may want to use the chemical epitope logics for data collection and analysis. In most cases, toxicity evaluation is driven by chemical use and its known toxicity. That is, toxicity studies focus on compounds that we are significantly exposed to or that are identified as potentially toxic at dose levels similar to exposure levels. This seems a sound way of using the available resources. However, I
propose that we also need to devote a significant amount of resources to evaluate toxicity for families of chemicals defined by a particular chemical epitope, as this may generate knowledge particularly useful for the final goal of in silico prediction. One example of the potential interest of this approach is the work by LoPachin et al. (2008) raising the hypothesis that conjugated ,-unsaturated carbonyl derivatives (that is, chemicals containing this particular chemical epitope) are particularly prone to cause neurotoxicity by presynaptic damage via protein adduct formation. Another example is the study on the neurotoxic effects of nitriles (compounds with a cyano, R-CN, group) on the sensory and central nervous systems. Many nitriles are known to cause acute toxicity through cyanide release by xenobiotic metabolism enzymes, a toxic endpoint already addressed by some modeling studies (Grogan et al., 1992) . The work by several groups, including ours, has demonstrated that several nitriles cause a variety of neurotoxic effects, such as degeneration of specific populations of neurons in the central nervous system (Boadas-Vaello et al., 2005; Seoane et al., 2005) and degeneration of sensory systems including the olfactory (Genter et al., 1992) , auditory (Gagnaire et al., 2001 ) and vestibular systems (Llorens et al., 1993; Llorens, 2001, 2003) . We have observed that vestibular toxicity is not related to cyanide release (Boadas-Vaello et al., 2007 ) and is associated with strict structural requirements (Balbuena and Llorens, 2003) that may depend on the animal species, as the case of trans-crotononitrile, which causes neuronal degeneration in the rat (Boadas-Vaello et al., 2005; Seoane et al., 2005) and vestibular toxicity in the mouse (Saldaña-Ruíz et al., 2012 ). An evaluation of 19 similar nitriles for vestibular toxicity in the mouse has resulted in 5 positive nitriles (Saldaña-Ruíz et al., 2012) . We hypothesize that the nitrile group has a diverse but limited number of neurotoxic effects, and that the structural motifs leading to each one of them will be amenable to modeling. That is, we will probably be able to define a small number of chemical epitopes containing the nitrile group and causing different neurotoxic effects, and to model the relationship between chemical structure and neurotoxicity for all of them. As these relationships most often depend on chemical-to-protein interaction, speciesspecific differences emerge, but these will be included in the models.
Similarly to the above examples, any given group or chemical epitope may have a diverse but probably limited number of toxic effects. Detection and characterization of all these effects for future modeling and prediction looks like an enormous task. To begin with, one would like to have an estimate of its size, as imprecise as it may be.
My hypothesis is that the numbers provided by the olfactory system, from several hundreds to a few housand epitopes, provide such a rough estimate and it does not look impossible in a century perspective.
Neurotoxicity Testing: The Challenge Of In Vitro Alternatives
Sandra Ceccatelli. Department of Neuroscience, Karolinska Institutet, Stockholm,
Sweden
The complex anatomical and physiological organization of the nervous system, with different cell types forming networks essential to maintain all integrated functions, cannot be reproduced in in vitro systems. However, the use of multiple in vitro models, including primary cultures of neurons obtained from specific brain areas, cell lines of different origin, co-culture systems with neuronal and glial cells, have been shown to be valuable in neurotoxicological research. The nervous system is particularly sensitive to alterations of the microenvironment occurring during development, and there is growing evidence pointing to developmental exposure to chemicals as possible cause of nervous system disorders (Landrigan et al., 2005) . Well characterized in vitro model systems are therefore needed for large scale "animal-free" screening of chemicals and pharmaceutical drugs for the assessment of neurotoxic effects, with special focus on developmental neurotoxicity (DNT).
In recent years, we have successfully implemented the use of neural stem cells (NSCs) as models for in vitro DNT tests (Sleeper et al., 2002; Tamm et al., 2004 Tamm et al., , 2006 Tamm et al., , 2008a . NSCs play a critical role in the developing embryonic nervous system through to adulthood, where the ability for self-renewal appears to be important for normal functions, such as learning, memory, and response to injuries. Using NSCs from rodents and humans, we have investigated the effects of environmental contaminants, such as methylmercury (MeHg) and non-dioxin-like polychlorinated biphenyls (PCBs) on survival and differentiation potential.
We prepare primary cultures of NSCs from embryonic cortices from timed- antagonistic interaction on spontaneous neuronal differentiation of NSCs (Tofighi et al. 2011b ).
With regard to human NSCs, after several tests, we came to the conclusion that for proliferation or differentiation assays, dissociated cells provide the most reliable results. For migration assays instead, we implemented intact neurospheres. Cells from different developmental stages cultured as neurospheres were exposed to a range of MeHg concentrations (2.5nM, 10nM, 25nM, 100nM) and alterations in differentiation and migration were examined and compared to untreated control-cultures processed in parallel. Exposure to MeHg (10 -25nM) resulted in a significant decrease in neuronal differentiation (Tuj1 quantification), similar to what was observed in rodent NSCs (Edoff et al. unpublished).
In conclusion, it appears that NSCs are promising in vitro models for neurotoxicity studies and that parameters such as cell proliferation, differentiation and migration are sensitive endpoints to identify substances with developmental neurotoxic potential.
Cell-Based Methods for Predicting Neurotoxicity of Environmental Pollutants
Cristina Suñol. Department of Neurochemistry and Neuropharmacology. Institut d'Investigacions Biomèdiques de Barcelona. IIBB-CSIC-IDIBAPS; CIBERESP.
Barcelona. Spain. E-mail: csenqi@iibb.csic.es
More than 200 chemicals have been reported to produce neurotoxicity in humans and some of them. are permanent organic pollutants and bioaccumulate in food chains, contaminating the food and, therefore, posing a risk for human health (Grandjean and Landrigan, 2006) . This is the case, for example, with organochlorine pesticides, PCBs and methylmercury. Neurotoxicity is usually manifested as alterations of behavior including cognitive, motor and learning-memory processes, which are often a consequence of alterations in GABAergic and glutamatergic neurotransmission, and of neurodegenerative processes. Recent studies demonstrated the presence of environmental contaminants in human samples, including those from children. In fact, persistent organochlorine pesticides and methylmercury have been found with high frequency in placenta, cord blood and children's adipose tissue (López-Espinosa et al., 2007 Ramon et al., 2011; Younglai et al., 2002) . Furthermore, epidemiological studies found correlations between exposure to these neurotoxicants and neurological deficits in children (Grandjean and Landrigan, 2006; Morales et al., 2008; Freire et al., 2010) . Therefore, toxicity testing is needed for predicting neurotoxicity of low-and longterm exposure to environmental pollutants. To this aim, we use primary neuronal cultures as experimental models for neurotoxicity testing.
Primary cultures of mouse cerebellar granule cells consist mainly of glutamatergic neurons (> 90 %) with a small proportion of GABAergic neurons (~ 6 %), whereas primary cultures of mouse cortical neurons contain both GABAergic, cholinergic and glutamatergic neurons as the main neuronal types (Solà et al., 2011; Sonnewald et al., 2004; Suñol et al., 2008) . Moreover, the functional expression of GABA-A, glutamate, glycine and cholinergic receptors, as well as neuronal transporters for glutamate and GABA and enzymes for the synthesis/degradation of these neurotransmitters is well documented in the literature. It has been reported that neurons develop in vitro faster than in vivo (Yu et al., 1984) acquiring characteristics of GABA and glutamate neurotransmisión within 1 -2 weeks in culture (Yu et al., 1984; Frandsen and Schousboe, 1990; Griffiths et al., 1997; Hogberg et al., 2010) . Therefore, cells can be exposed to chemicals either at maturation (after 1 week in vitro) or during their differentiation to study neurodevelopmental toxic effects/mechanisms of toxicity.
We present here our recent findings on the prolonged effects of environmental persistent pollutants on GABA and glutamate neurotransmission, on redox homeostasis and on cytoskeletal proteins in primary rodent cultured neurons. Accordingly, this in vitro inhibition will be predictive of an excitatory syndrome that eventually can lead to the induction of convulsions in mammals. However, this continuous inhibiton of the GABA A receptor might also induce a synaptic scaling compensatory effect, scaling down excitatory glutamate receptors to protect the CNS system from imbalance of excitatory-inhibitory neurotransmission (Watt et al., 2000) .
We found that prolonged in vitro exposure of cultured neurons to dieldrin resulted in decreased functionality of ionotropic NMDA and type I metabotropic mGluR5 glutamate receptors. This decreased activity was accounted for by internalization and downregulation of NMDA and mGluR5 receptors, respectively (Babot et al., 2005; Briz et al., 2010) . Figure 1 summarizes the effects of prolonged exposure to a non-toxic concentration of dieldrin on glutamatergic neurotransmission in primary cultures of cortical neurons. From these findings we conclude that prolonged exposure to dieldrin in vitro led to reduced performance of the GABA A and glutamate receptors, which may be predictive of deleterious consequences in vivo because NMDA receptor is involved in memory and learning processes. In fact, behavioral and learning deficits have been observed in monkeys chronically dosed with dieldrin (Smith et al., 1976 (Briz et al., 2011) . These effects of dieldrin on ER levels and activation might contribute to cognitive and behavioral deficits (Schantz and Widholm, 2001 ).
Methylmercury is a neurotoxic agent to which the population is exposed through consumption of predator fishes that have bioaccumulated it (McDowell et al., 2004; Ramon et al., 2011) . Targets of methylmercury in the CNS are the granule cell layer of the cerebellum and the cortex visual area. In cultured cerebellar granule cells, acute exposure to methylmercury inhibits neuronal glutamate uptake, increases extracellular glutamate, produces reactive oxygen species and increases intracellular calcium (Allen et al., 2001; Fonfría et al., 2005; Gassó et al., 2001) . Methylmercury-induced cell death was concentration-and time-dependent in cerebellar granule cells. Prolonged exposure of cerebellar granule cells during maturation in vitro to methylmercury resulted in reduced glutathione peroxydase (GPx) activity before methylmercury induced neuronal death, which was related to enhanced susceptibility to hydrogenperoxide. Accordingly, lipid peroxidation was produced, which was reversed by the antioxidant probucol. At the same time, probucol increased GPx activity. Likewise, overexpression of GPx-1 in cultured cerebellar granule cells resulted in neuroprotection against methylmercury-induced cell death (Farina et al., 2009) . Figure 2 summarizes some of these findings. On the other hand, no effects were found in reduced and oxidized glutathione levels, glutathione reductase and catalase activity, nor on neuronal glutamate uptake or intracellular calcium, after using the same protocol for methylmercury exposure (Farina et al., 2009) . Altogether, these results suggest that oxidative stress driven by inhibition of glutathione peroxidase may be one of the first hallmarks of methylmercury-induced neurotoxicity in the development of cerebellar granule cells, a finding also observed in mice exposed to methylmercury (Franco et al., 2009 ). Under similar in vitro exposure conditions, an increase in non-phosphorylated cofilin and translocation of non-phosphorylated cofilin from the cytosol to the mitochondria was also found by means of a proteomic approach (Vendrell et al., 2010) .
The balance of cofilin phosphorylation / non-phosphorylation forms regulates actin dynamics and facilitates actin filament turnover, which are responsible for neuron shape change, migration, polarity formation and regulation of synaptic structures and function. Therefore, an alteration of the complex regulation of the cofilin phosphorylation/dephosphorylation pathway could be envisaged as an underlying mechanism compatible with reported signs of methylmercury-induced neurotoxicity such as those observed in vivo (apoptosis, cell migration deficits).
.
In conclusion, cell-based methods using primary neuronal cultures of different cell types (cortical neurons and cerebellar granule neurons) constitute good models for testing the neurotoxicity of environmental pollutants. Non-cytotoxic concentrations of the agents have been used and this allowed us to determine their effects on neural functions in the absence of general toxicity. Following the recommendations of the US National Academies, I have shown that these models may be incorporated into a predictive strategy based on in vitro toxicity assays, because they are able to predict at a cellular level effects that can be extrapolated to effects on individuals.
Conclusion.
Toxicity prediction is particularly challenging in the case of chronic neurotoxicity and neurodevelopmental toxicity effects, and these areas place a particular challenge to the NRC 21 st century vision strategy. In the symposium reported here, a comparison was presented on the current and proposed approaches to neurotoxicity testing, highlighting critical questions that need to be addressed and are of particular relevance in the transition from the present to the future approaches. While recognizing the difficulties ahead, this talk provided a hopeful view of significantly ameliorating our testing strategies for neurotoxicity prediction. An alternative view was presented at the symposium, defending that the goal of a complete in silico neurotoxicity prediction is possible in the very long term, but that approaching this goal will require the use of in vivo studies to collect large amounts of toxicity data for chemical epitopes. Within the predominant strategy of moving towards an increasing role for in vitro test systems, we need to know how subtle effects on brain function and development resulting from low dose or chronic exposure can be evaluated in these systems. The results discussed on this synopsis on neural stem cells and on long-term neuronal culture effects showed that in vitro systems can go beyond cytotoxicity assessment, and be useful in evaluating adverse functional effects likely relevant to chronic and developmental neurotoxicity. Evolving these contributions into practical tools for toxicity prediction is a challenging endeavor. 
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